ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried?

According to the 13F filing with the Securities and Exchange Commission dated Nov. 12, 2025, ARK Investment Management sold ...

CRISPR Therapeutics's Options Frenzy: What You Need to Know

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

CRISPR Therapeutics Post Q3 Earnings: Testing Investor Patience, But Still A Buy

CRISPR Therapeutics AG is rated a Buy with $1.9B cash, prudent management, and undervalued shares. Learn more about CRSP ...
TipRanks on MSN

Crispr Therapeutics’ Long-term Study on CAR T Therapies: A Market Game Changer?

Crispr Therapeutics (($CRSP)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Long-term Follow-up ...
News-Medical.Net

Using CRISPR-Cas9 to uncover and target the genetic basis of obesity

CRISPR-Cas9 is a promising approach for obesity therapy, targeting key genes involved in appetite regulation, metabolism, and ...
Drexel University

Chemistry Seminar: An Overview of Genome Editing: CRISPR and Beyond

Genome editing refers to our ability to make directed changes at specific sites in the DNA sequence in cells of an organism. Several different techniques for genome editing have been developed, and ...
ucdavis.edu

Can CRISPR Cut Methane Emissions From Cow Guts?

Ermias Kebreab, left, and Matthias Hess, right, with the College of Agricultural and Environmental Sciences, will work with UC collaborators to cut methane emissions from cow guts using the ...
EurekAlert!

An overview of CRISPR-Cas9-mediated imaging of genomic loci in cells (IMAGE)

This includes the labeling of the dCas9 protein, engineering of sgRNA, and the use of dCas9 orthologs from different bacterial species. CRISPR, clustered regularly interspaced short palindromic ...